Published • loading... • Updated
Celon Pharma’s generic semaglutide drug matches Ozempic in early study, shares jump
1 Articles
1 Articles
Celon Pharma’s generic semaglutide drug matches Ozempic in early study, shares jump
Aug 20 (Reuters) - Celon Pharma's experimental semaglutide product Reduzek, a generic alternative to Novo Nordisk's Wegovy and Ozempic, matched the blockbuster weight-loss drugs in an early-stage bioequivalence study, the Polish drugmaker said on Thu...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
